AGNELLI, Giancarlo
 Distribuzione geografica
Continente #
NA - Nord America 17.214
EU - Europa 12.156
AS - Asia 11.341
SA - Sud America 2.207
AF - Africa 301
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 15
Totale 43.252
Nazione #
US - Stati Uniti d'America 16.838
SG - Singapore 5.576
UA - Ucraina 2.210
IE - Irlanda 2.156
RU - Federazione Russa 1.860
BR - Brasile 1.696
IT - Italia 1.619
CN - Cina 1.461
HK - Hong Kong 1.297
VN - Vietnam 1.245
SE - Svezia 962
DE - Germania 889
FR - Francia 719
FI - Finlandia 678
GB - Regno Unito 409
KR - Corea 286
IN - India 268
TR - Turchia 240
BD - Bangladesh 205
CA - Canada 174
AR - Argentina 158
IQ - Iraq 129
MX - Messico 112
AT - Austria 103
PL - Polonia 100
PK - Pakistan 90
EC - Ecuador 83
ZA - Sudafrica 81
NL - Olanda 80
CH - Svizzera 78
UZ - Uzbekistan 74
CO - Colombia 69
JP - Giappone 67
VE - Venezuela 67
SA - Arabia Saudita 57
ES - Italia 54
BE - Belgio 52
CL - Cile 49
ID - Indonesia 49
LB - Libano 46
PH - Filippine 41
MA - Marocco 40
LT - Lituania 36
TN - Tunisia 36
CZ - Repubblica Ceca 35
EG - Egitto 35
JO - Giordania 31
KE - Kenya 29
GR - Grecia 28
PY - Paraguay 27
CR - Costa Rica 20
MY - Malesia 20
BO - Bolivia 19
JM - Giamaica 19
AE - Emirati Arabi Uniti 18
UY - Uruguay 18
PE - Perù 16
KG - Kirghizistan 15
OM - Oman 14
AZ - Azerbaigian 13
IL - Israele 13
RO - Romania 13
AL - Albania 12
DZ - Algeria 12
PA - Panama 12
PS - Palestinian Territory 12
SK - Slovacchia (Repubblica Slovacca) 12
TH - Thailandia 11
ET - Etiopia 10
EU - Europa 10
NG - Nigeria 10
BG - Bulgaria 9
KZ - Kazakistan 9
NP - Nepal 9
HR - Croazia 7
SY - Repubblica araba siriana 7
AU - Australia 6
BH - Bahrain 6
CI - Costa d'Avorio 6
EE - Estonia 6
KW - Kuwait 6
NZ - Nuova Zelanda 6
SN - Senegal 6
TT - Trinidad e Tobago 6
XK - ???statistics.table.value.countryCode.XK??? 6
AO - Angola 5
GE - Georgia 5
GT - Guatemala 5
GY - Guiana 5
LY - Libia 5
PT - Portogallo 5
BY - Bielorussia 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
HN - Honduras 4
KH - Cambogia 4
NI - Nicaragua 4
SV - El Salvador 4
GA - Gabon 3
QA - Qatar 3
Totale 43.182
Città #
Singapore 3.831
Chandler 2.342
Dublin 2.146
San Jose 1.341
Hong Kong 1.288
San Mateo 1.222
Jacksonville 1.134
Ashburn 959
Boardman 751
Santa Clara 687
Dong Ket 681
Altamura 671
Moscow 645
Medford 581
Princeton 575
Lauterbourg 516
Lawrence 501
Des Moines 494
Wilmington 396
Ann Arbor 383
Andover 360
Perugia 358
Seoul 284
Beijing 281
Los Angeles 231
Munich 219
Ho Chi Minh City 200
The Dalles 196
New York 195
Saint Petersburg 174
São Paulo 158
Izmir 146
Helsinki 139
Hanoi 138
Piscataway 123
Norwalk 114
Shanghai 95
San Paolo di Civitate 93
Frankfurt am Main 79
Redmond 67
Dallas 66
Turku 66
Brooklyn 64
Chicago 64
Rome 63
Tokyo 61
Nuremberg 59
Orem 58
Montreal 56
Warsaw 54
Rio de Janeiro 53
Brussels 51
Baghdad 49
Chennai 49
Houston 49
Stockholm 46
Johannesburg 44
Atlanta 43
Boston 42
Belo Horizonte 40
Ottawa 40
Lahore 39
London 39
Woodbridge 39
Columbus 37
Denver 36
Falls Church 36
Dearborn 35
Phoenix 35
Brasília 34
San Francisco 33
Hefei 32
Seattle 32
Amsterdam 31
Mexico City 31
Manchester 30
Redwood City 29
Tashkent 29
Jeddah 28
Mumbai 28
Vienna 28
Amman 27
Toronto 27
Da Nang 26
New Delhi 26
Ankara 25
Council Bluffs 25
Den Haag 25
Guangzhou 25
Poplar 25
Nairobi 24
Philadelphia 24
Charlotte 23
Guayaquil 23
Medellín 22
Auburn Hills 20
Caracas 20
Dhaka 20
Falkenstein 20
Istanbul 20
Totale 27.019
Nome #
Bedside sonography assessment of extravascular lung water increase after major pulmonary resection in non-small cell lung cancer patients 148
Systemic thrombolysis in patients with acute ischemic stroke and internal carotid artery occlusion: The ICARO study 145
Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model 142
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 141
A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: The @RISTOS Project 137
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 135
Anticoagulation after Stroke in Patients with Atrial Fibrillation: To Bridge or Not with Low-Molecular-Weight Heparin? 135
Acute myocardial infarction and heart failure in acute stroke patients: frequency and influence on clinical outcome. 134
Arterial hypertension as risk factor for spontaneous cervical artery dissection. A case-control study 131
Aspirin for preventing the recurrence of venous thromboembolism. 130
Acute stroke symptoms: Do differences exist between sexes? 130
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 130
Causes and Risk Factors of Cerebral Ischemic Events in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention: The RENo Study 126
Prestroke CHA2DS2-VASc Score and Severity of Acute Stroke in Patients with Atrial Fibrillation: Findings from RAF Study 125
Angiographic findings of moyamoya vessels in a patient with rheumatoid arthritis 124
Epidemiology of cerebral vein and sinus thrombosis. 123
Prognostic value of trans-thoracic echocardiography in patients with acute stroke and atrial fibrillation: findings from the RAF study 121
Early admission to stroke unit influences clinical outcome 118
Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: Time to initiation of oral anticoagulant therapy and outcomes 118
[Spinal anesthesia and prophylaxis of venous thromboembolism. Results of a national survey]. 117
Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke. 116
Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study 115
Alcohol intake and the risk of intracerebral hemorrhage in the elderly: The MUCH-Italy 115
Severity of acute intracerebral haemorrhage, elderly age and atrial fibrillation: Independent predictors of poor outcome at three months 115
A Clinical Outcome-Based Prospective Study on Venous Thromboembolism After Cancer Surgery The @RISTOS Project 114
96 hours ECGmonitoring for patients with ischemic cryptogenic stroke or transient ischaemicattack. 113
Secondary stroke prevention in women. 113
Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients with Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score Study 111
Sex-related differences in risk factors, type of treatment received and outcomes in patients with atrial fibrillation and acute stroke: Results from the RAF-study (Early Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation) 110
A prospective study on cardiovascular events after acute pulmonary embolism 109
Chemotherapy-associatedthromboembolic risk in cancer outpatients and effect of nadroparinthromboprophylaxis: results of a retrospective analysis of the PROTECHT study. 109
Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome 109
[Effect of platelet-derived growth factor on the in vitro cell proliferation of chick embryo skin]. 108
Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study. 108
Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study 108
Predictive value of admission blood glucose level on short-term mortality in acute cerebral ischemia. 107
Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study. 107
Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry. 107
Acute pulmonary embolism: external validation of the 2014 risk stratification model of the European Society of Cardiology 107
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 107
Dermatan sulphate for heparin-induced thrombocytopenia and central venous catheter related deep vein thrombosis in a child with acute lymphoblastic leukemia 106
Efficacy of thrombolytic (rt-PA) therapy in old stroke patients: the Perugia Stroke Unit experience 106
Acute pulmonary embolism: external validation of an integrated risk stratification model. 106
Cancer-associated ischemic stroke: A retrospective multicentre cohort study 106
Lessons learned from the global orthopaedic registry: study design, current practice patterns, and future directions. 105
A sudden neurological deficit in a patient with endocarditis. 105
Admission Leukocytosis in Acute Cerebral Ischemia: Influence on Early Outcome. 105
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism 105
Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis 105
Patients aged 90  years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study 105
Anticoagulation for atrial fibrillation in patients with active cancer: Reply to the ‘Letter to the Editor’ from Dr. Sorigue et al 105
Definition of major bleeding: Prognostic classification 105
A new strategy for anticoagulation: The factor XI inhibitors 104
Is antithrombotic prophylaxis required in cancer patients with central venous catheters? No. 104
[Acute immunoallergic thrombopenia due to sulfamethoxazole-trimethoprim]. 104
Gene-drug interaction in stroke. 103
Venous thromboembolism associated with long-term use of central venous catheters in cancer patients 103
Risk factors for venous thromboembolism in the elderly: results of the master registry. 103
A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score. 103
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 103
A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. 103
Cardiac hemangioma of the right atrium: a possible cause of cerebellar stroke. 102
Bosentan for chronic thromboembolic pulmonary hypertension: findings from a systematic review and meta-analysis. 102
Prevention of venous thromboembolism in surgical patients 101
Association of persistent right ventricular dysfunction at hospital discharge after acute pulmonary embolism with recurrent thromboembolic events 101
Initial treatment of venous thromboembolism 101
Arterite temporale occulta: contributo casistico e revisione della letteratura 101
[Heparin in anesthesia. Pharmacological and clinical aspects in the prophylaxis of venous thromboembolism]. 101
Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with Non-Vitamin-K oral anticoagulants (RAF-NOACs) Study 101
Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion: the ICARO-3 study 101
Lacunar stroke syndromes as predictors of lacunar and non-lacunar infarcts on neuroimaging: a hospital-based study 101
Isolated monoparesis following stroke 100
A randomised, double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture. 100
Risk Profile of Symptomatic Lacunar Stroke Versus Nonlobar Intracerebral Hemorrhage 100
Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcme-based meta-analysis 100
Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation 100
Prevalence of thrombophilic genetic mutations in patients undergoing thrombotic events while on oral anticoagulants a case-control study 100
Risk factors for adverse short-term outcome in patients with pulmonary embolism 99
Sulodexide in the treatment of intermittent claudication. Results of a randomized, double-blind, multicentre, placebo-controlled study. 99
Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. 99
Are placebo-controlled trials ethical in areas where current guidelines recommend therapy? No 99
Acute pulmonary embolism. 99
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 99
The good use of plasma. A critical analysis of five international guidelines. 99
Clinical skills or high-tech MR in TIA patients: what makes the difference? 99
A prospective study on survival in cancer patients with and without venous thromboembolism. 99
Pattern of in-hospital changes in drug use in the older people from 2010 to 2016 98
Risk factor for upper limb deep vein thrombosis 98
D-dimer for riskstratification in patients with acute pulmonary embolism. 98
Acute pulmonary embolism: risk stratification in the emergency department. 98
Risk of recurrent venous thromboembolism after acute pulmonary embolism: Role of residual pulmonary obstruction and persistent right ventricular dysfunction. A meta-analysis 98
Dermatan sulphate in patients with heparin-induced thrombocytopenia. 97
[Determinants of prognosis in acute pulmonary embolism: the role of serum troponins]. 97
Factors associated with the timing of diagnosis of venous thromboembolism: results from the MASTER registry. 97
[Prevention of venous thromboembolism in orthopedic surgery and traumatology]. 97
Cervical artery dissection: emerging risk factors. 97
Early recurrence in paroxysmal versus sustained atrial fibrillation in patients with acute ischaemic stroke 97
Vascular cognitive impairment: a pragmatic concept 96
Profilassi della trombosi venosa profonda in neurochirurgia 96
Heparin in anesthesia. Pharmacological and clinical aspects in the prophylaxis of venous thromboembolism 96
Totale 10.875
Categoria #
all - tutte 209.916
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 209.916


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021732 0 0 0 0 0 0 0 0 0 0 0 732
2021/20224.446 53 780 64 153 232 31 46 1.540 68 167 469 843
2022/20238.339 663 1.638 121 542 651 1.170 21 340 2.832 23 264 74
2023/20242.458 205 309 189 40 47 22 475 123 164 119 427 338
2024/20256.653 52 714 151 240 924 326 179 510 1.438 429 1.052 638
2025/202614.187 1.217 868 729 1.822 1.870 1.244 2.582 741 1.472 1.148 350 144
Totale 44.276